Centene Corp: Form 10-Q for the period ended Mar 31, 2022
Filed with the SEC on Apr 26, 2022 and accepted by EDGAR at Apr 26, 2022, 00:49 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-01-01 to 2022-03-31 | $34.23bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2022-01-01 to 2022-03-31 | $1.99bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2022-01-01 to 2022-03-31 | $2.75bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2022-01-01 to 2022-03-31 | $1.25bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2022-01-01 to 2022-03-31 | $160.0m | us-gaap:InterestExpense |
| Income tax | 3 months2022-01-01 to 2022-03-31 | $296.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-01-01 to 2022-03-31 | $849.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-01-01 to 2022-03-31 | $1.44 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-01-01 to 2022-03-31 | $1.46 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-01-01 to 2022-03-31 | 590,658,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2022-01-01 to 2022-03-31 | $1.15bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2022-01-01 to 2022-03-31 | $242.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months2022-01-01 to 2022-03-31 | $71.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-03-31 | $11.24bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-03-31 | $31.11bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-03-31 | $82.90bn | us-gaap:Assets |
| Current liabilities | At period end2022-03-31 | $29.68bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-03-31 | $55.47bn | us-gaap:Liabilities |
| Long-term debt | At period end2022-03-31 | $18.64bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2022-03-31 | $292.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2022-03-31 | $27.17bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001071739-22-000177. Last ingested by Listed: Oct 24, 2026, 15:03 ET. Listed shows no prices and gives no investment advice.